COMMUNIQUÉS West-GlobeNewswire

New APOE4 App Uses AI Digital Twins to Help 25% of Population at High Alzheimer's Risk
18/07/2025
Phoenix platform matches users with genetically similar people to predict which interventions actually work. SINGAPORE, July 18, 2025 (GLOBE NEWSWIRE) -- The Phoenix today launched the alpha version of the first app [...]
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
18/07/2025
SAN CARLOS, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18/07/2025
NOVATO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare [...]
HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock
18/07/2025
NEW YORK and VIENNA, July 18, 2025 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, “HOOKIPA”), a clinical-stage biopharmaceutical company developing next-generation immunotherapeutics for the treatment of cancer [...]
Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
18/07/2025
CAMBRIDGE, Mass., July 18, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that, effective as of July 17, 2025, [...]
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
18/07/2025
SOUTH SAN FRANCISCO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on July 16, 2025 it granted stock options to purchase an aggregate of 131,683 shares of [...]
Human Appeal USA Mobilizes Relief and Volunteer Event for Texas Flood Victims
18/07/2025
Dallas-based nonprofit leads volunteer health kit packing event and launches nationwide donation drive to support families affected by Texas floods DALLAS, July 18, 2025 (GLOBE NEWSWIRE) -- In the wake of devastating [...]
Tevogen.AI Receives International Patent Publication for AI Technology Predicting Immunologically Active Peptides
18/07/2025
WARREN, N.J., July 18, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) announced today that the International Bureau of the World Intellectual Property Organization (WIPO) has [...]
Zealand Pharma major shareholder announcement: Van Herk Investments B.V.
18/07/2025
Company announcement – No. 17 / 2025 Zealand Pharma major shareholder announcement: Van Herk Investments B.V. Copenhagen, Denmark, July 18, 2025 – Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20045078), a [...]
Anosh Inc Foundation Establishes Super PAC to Promote Legislative Priorities Across Illinois
18/07/2025
New Super PAC will advocate for property tax reform, public safety, and fiscal responsibility to improve quality of life for Illinois communities Dr. Anosh Ahmed Image CHICAGO, July 18, 2025 (GLOBE NEWSWIRE) -- The [...]
Anosh Inc Foundation Announces Illinois-Based Super PAC to Support Community-Focused Policy Priorities
18/07/2025
New initiative aims to promote reforms in public safety, tax policy, and fiscal transparency through nonpartisan civic engagement Dr. Anosh Ahmed Image CHICAGO, July 18, 2025 (GLOBE NEWSWIRE) -- The Anosh Inc Foundation [...]
Disclosure of notification received from Alychlo
18/07/2025
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 18 July 2025 – 6 PM CET Disclosure of notification received from Alychlo Fagron received a notification based on the Belgian law of 2 May 2007 [...]
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
18/07/2025
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – STAMFORD, Conn., July 18, [...]
European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN
18/07/2025
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms – STAMFORD, Conn., July 18, [...]
Hapbee Reports First-Ever Quarterly Profit in Q2 2025 and Achieves Third Consecutive Quarter of Growth
18/07/2025
Strong top-line gains, reduced expenditures, and improved gross margins result in milestone quarter VANCOUVER, British Columbia, July 18, 2025 (GLOBE NEWSWIRE) -- Hapbee Technologies Inc. (TSXV: HAPB | OTCQB: HAPBF), a [...]
Muscle Gain & Strength Supplements: How CrazyBulk Muscle Building Supplements Boost Strength and Maximize Muscle Performance Fast
18/07/2025
Explore how CrazyBulk legal muscle building supplements power muscle gain, improve muscle strength, and unlock next-level muscle performance in 2025. New York City, NY, July 18, 2025 (GLOBE NEWSWIRE) -- In the ever- [...]
EURneffy® (adrenaline nasal spray) Approved in the U.K. as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
18/07/2025
EUR neffy ( neffy ® in the U.S.) offers a new delivery method for adrenaline in the U.K. for adults and children ( > 30 kg) living with severe allergic reactions ALK-Abelló A/S, which owns the rights to market EUR [...]
Connect Biopharma to Participate in the BTIG Virtual Biotechnology Conference
18/07/2025
SAN DIEGO, July 18, 2025 (GLOBE NEWSWIRE) -- Connect Biopharma Holdings Limited (Nasdaq: CNTB) (“Connect Biopharma”, “Connect”, or the “Company”), a clinical-stage biopharmaceutical company focused on transforming care [...]
Senti Bio Appoints Entrepreneurial Leader and Investor, Bryan Baum, to Board of Directors
18/07/2025
SOUTH SAN FRANCISCO, Calif., July 18, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene [...]

Pages